Edition:
United States

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

59.90CHF
11:30am EDT
Change (% chg)

CHF-0.80 (-1.32%)
Prev Close
CHF60.70
Open
CHF60.50
Day's High
CHF60.50
Day's Low
CHF57.75
Volume
190,404
Avg. Vol
47,155
52-wk High
CHF84.10
52-wk Low
CHF57.75

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 4 115.32 129.50 104.00 94.45
Year Ending Dec-19 4 134.30 155.80 121.09 122.60
Earnings (per share)
Year Ending Dec-18 3 -2.26 -1.11 -3.24 -2.35
Year Ending Dec-19 4 -1.16 0.81 -2.73 -0.61
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.67 30.17
P/E High - Last 5 Yrs. -- 268.68 47.22
P/E Low - Last 5 Yrs. -- 94.38 24.76
Beta 1.17 0.78 0.85
Price to Sales (TTM) 7.84 251.80 7.96
Price to Book (MRQ) -- 12.51 3.68
Price to Tangible Book (MRQ) -- 22.18 5.57
Price to Cash Flow (TTM) -- 61.34 20.80
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.38 1.79
Dividend Yield - 5 Year Avg 0.00 0.21 1.46
Dividend 5 Year Growth Rate -- 2.50 -6.02
Payout Ratio(TTM) -- 6.29 46.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 13.25 157.04 7.11
Sales (TTM) vs TTM 1 Yr. Ago 25.69 90.91 11.85
Sales - 5 Yr. Growth Rate 9.39 24.11 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -9.24 91.80 23.72
EPS (TTM) vs TTM 1 Yr. Ago 53.33 -- --
EPS - 5 Yr. Growth Rate -- 23.11 7.49
Capital Spending - 5 Yr. Growth Rate -6.48 36.56 8.05

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.66 1.72 2.50
Current Ratio (MRQ) 3.97 5.43 3.54
LT Debt to Equity (MRQ) -- 19.83 11.28
Total Debt to Equity (MRQ) -- 23.67 14.23
Interest Coverage (TTM) -5.84 -188.31 32.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 87.54 58.15 55.18
Gross Margin - 5 Yr. Avg. -- 52.69 53.35
EBITD Margin (TTM) -15.53 -- --
EBITD - 5 Yr. Avg -62.72 -191.22 15.81
Operating Margin (TTM) -17.52 -1,104.16 -2.55
Operating Margin - 5 Yr. Avg. -66.92 -204.63 10.94
Pre-Tax Margin (TTM) -21.84 -989.95 -0.67
Pre-Tax Margin - 5 Yr. Avg. -70.84 -205.61 11.10
Net Profit Margin (TTM) -22.20 -981.23 -3.87
Net Profit Margin - 5 Yr. Avg. -71.12 -203.21 7.45
Effective Tax Rate (TTM) -- 12.10 20.32
Effective Tax Rate - 5 Yr. Avg. -- 18.73 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) 417,952 5,056,061 723,095,676
Net Income/Employee (TTM) -92,796 -5,576,115 84,116,797
Receivable Turnover (TTM) 25.72 6.52 5.40
Inventory Turnover (TTM) 0.69 2.27 3.53
Asset Turnover (TTM) 0.32 0.43 0.84

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -7.13 2.18 10.09
Return on Assets - 5 Yr. Avg. -12.56 2.43 10.96
Return on Investment (TTM) -9.33 3.33 12.67
Return on Investment - 5 Yr. Avg. -15.74 1.79 14.16
Return on Equity (TTM) -- 2.31 14.86
Return on Equity - 5 Yr. Avg. -147.00 -7.00 15.52
  1 Year 3 Year 5 Year
Sales % 39.42 28.74 9.39
EPS (TTM) % 64.77 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -7.82 -8.47 99 23
13 Week -16.04 -16.13 99 51
26 Week -11.64 -12.43 99 47
52 Week -22.53 -22.18 99 82
YTD -20.03 -16.61 99 75
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 31.61%
# of Holders: 73
Total Shares Held: 3,754,356
3 Mo. Net Change: 19,616
# New Positions: 4
# Closed Positions: 4
# Increased Positions: 15
# Reduced Positions: 9
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.